Correlation Between Larimar Therapeutics and Eliem Therapeutics
Can any of the company-specific risk be diversified away by investing in both Larimar Therapeutics and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Larimar Therapeutics and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Larimar Therapeutics and Eliem Therapeutics, you can compare the effects of market volatilities on Larimar Therapeutics and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Larimar Therapeutics with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Larimar Therapeutics and Eliem Therapeutics.
Diversification Opportunities for Larimar Therapeutics and Eliem Therapeutics
-0.05 | Correlation Coefficient |
Good diversification
The 3 months correlation between Larimar and Eliem is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Larimar Therapeutics and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and Larimar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Larimar Therapeutics are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of Larimar Therapeutics i.e., Larimar Therapeutics and Eliem Therapeutics go up and down completely randomly.
Pair Corralation between Larimar Therapeutics and Eliem Therapeutics
Given the investment horizon of 90 days Larimar Therapeutics is expected to generate 0.77 times more return on investment than Eliem Therapeutics. However, Larimar Therapeutics is 1.29 times less risky than Eliem Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Eliem Therapeutics is currently generating about 0.04 per unit of risk. If you would invest 364.00 in Larimar Therapeutics on September 2, 2024 and sell it today you would earn a total of 269.00 from holding Larimar Therapeutics or generate 73.9% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 99.19% |
| Values | Daily Returns |
Larimar Therapeutics vs. Eliem Therapeutics
Performance |
| Timeline |
| Larimar Therapeutics |
| Eliem Therapeutics |
Larimar Therapeutics and Eliem Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Larimar Therapeutics and Eliem Therapeutics
The main advantage of trading using opposite Larimar Therapeutics and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Larimar Therapeutics position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.| Larimar Therapeutics vs. Vaxcyte | Larimar Therapeutics vs. Syndax Pharmaceuticals | Larimar Therapeutics vs. Merus BV | Larimar Therapeutics vs. Sutro Biopharma |
| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |